Pharmaceutical industry news

Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference

Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 2

A New Pancreatic Cancer Drug Could Buy Patients More Time

First human clinical trial to test precision form of FLASH proton therapy

Fortrea to Acquire Worldwide Clinical Trials Early Phase Business for $45M

Ondine Biomedical’s Nasal Photodisinfection reduced surgical site infections by 40% in Phase 3 pivotal study

Navigating the adoption of biomarker-informed trial enrollment beyond oncology

ASUS Partners with Qualcomm to Launch Pharmaceutical AI Assistant, Targeting 10,000-Unit Opportunity in Southern Taiwan's Smart Pharmacies

CPHI Pharma Awards 2026 finalists announced

Advances in risk assessment shift the calculus of early intervention trials for MASLD

North Highland Names Chris Kido Global Head of Life Sciences

Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience

Information about the criminal offence committed by a former employee of the University of Freiburg

Quantum PureFlow Standard Heat Exchanger High Flow

Blood-to-glycol leakage was identified in the heat exchanger during the procedure. Glycol compartmen...

LIFEPAK ® 35 Monitor/Defibrillator

Stryker has identified an issue with the LP35 where the device does not display the message "CHECK R...

LEO+ Intracranial Self Expandable Stent And Delivery System

As a precautionary measure, Balt Extrusion is voluntarily recalling specific ANRYV connector lots af...

BiCOAG Hemostasis Probe

Olympus determined that the affected products may have been manufactured without the designated amou...

North Highland Names Chris Kido Global Head of Life Sciences

Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience

Kane Biotech Expands Canadian Commercial Reach with Ontario Medical Supply Inc.

Novartis inks $3.2B subcutaneous drug delivery deal with Alteogen

PPBT Stock Squeezed Between Biotech Promise And Cash Crunch

Purple Biotech Receives U.S. Patent Allowance for Tri-Specific Antibody Constructs Supporting CAPTN-3 Platform

U.S. patent backs Purple Biotech (NASDAQ: PPBT) cancer antibody platform

No extra officers, tougher enforcement: What FSSAI praised in Tukaram Mundhe’s FDA drive

Novartis’ Rhapsido cuts MS progression in Phase 3 trial, teeing up Roche battle

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

China is a Threat to Biotech’s Massive Bull Run

New daily drug may offer alternative for those who cannot use CPAP machines

Explained | Why Sun Pharma is offering cheaper drugs to Trump administration?

Can-Fite Reports Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study

Can-Fite BioPharma to Evaluate Earlier Interim Analysis Timing in Phase III Namodenoson Study for Advanced Hepatocellular Carcinoma

Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)

Peptide innovator says the drug class is due for a rethink

A marketed injectable drug is expected to bring Lifecore revenue in 2028.

Teva Pharmaceutical Industries Ltd

People in a liver cancer study may be living longer than expected. Can-Fite may analyze the data sooner.

Newron announces completion of screening for enrollment in

Bio-Rad expands chromatography columns with Nuvia Ion Exchange

TRINITY BIOTECH PLC SEC Filing (Sep 2, 2026)

FY2026 Annual Results Short Form Announcement

FY2026 Annual Results Booklet

FY2026 Annual Results Presentation

Merck to Participate in the Wells Fargo 21st Annual Healthcare Conference

MHRA and Manchester NHS partner to bring safe healthcare innovations to patients sooner

Getting back into the lab – it’s not out of reach

Care Quality Commission (CQC) Adult Inpatient Survey results

Ono Pharmaceutical joins forces with Aitia for drug discovery in neurology

Abortion Pill Case Is Frozen Until December While a Federal Judge Waits for the FDA Review

Federal Regulators Add Their Strongest Warning to a Common Iron Infusion Over Dangerously Low Phosphate Levels

Novartis’ and BMS’ paused CAR T trials, RevMed’s pancreatic cancer approval, more MFN deals

Gustave Roussy fait évoluer sa gouvernance avec la nomination de Juliette Le Gelard comme directrice générale adjointe

Novartis remibrutinib, a high-efficacy oral BTK inhibitor, significantly reduces relapse rates and shows favorable safety profile in Phase III RMS trials

Novartis BTK inhibitor clears Phase III hurdle in relapsing MS

Regulatory round-up: 2 September 2026

Analysis of online pharmacy advertisements for non-FDA-approved treatments

Ono Pharmaceutical joins forces with Aitia for drug discovery in neurology

Qualcomm & ASUS Launch Pharmacy AI Agent for Drug Safety